Compare · CHD vs WALD
CHD vs WALD
Side-by-side comparison of Church & Dwight Company Inc. (CHD) and Waldencast plc (WALD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHD and WALD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- CHD is the larger of the two at $23.17B, about 106.0x WALD ($218.6M).
- Over the past year, CHD is up 1.3% and WALD is down 26.8% - CHD leads by 28.1 points.
- CHD has been more active in the news (10 items in the past 4 weeks vs 1 for WALD).
- CHD has more recent analyst coverage (25 ratings vs 11 for WALD).
- Company
- Church & Dwight Company Inc.
- Waldencast plc
- Price
- $97.78-0.28%
- $1.70-2.59%
- Market cap
- $23.17B
- $218.6M
- 1M return
- +0.38%
- +2.73%
- 1Y return
- +1.32%
- -26.78%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 10
- 1
- Recent ratings
- 25
- 11
Church & Dwight Company Inc.
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products in the United States and internationally. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; and cold remedy products under the ZICAM brand. It also provides specialty products, including animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast based prebiotic. In addition, the company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.
Waldencast plc
Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
Latest CHD
- SEC Form 4 filed by EVP Chief Tech&Global New Prod Linares Carlos G.
- SEC Form 4 filed by President and CEO Dierker Richard A
- SEC Form 4 filed by EVP of Strategy, M&A, and BP Buchert Brian D
- SEC Form 4 filed by Director Shearer Robert K
- SEC Form 4 filed by Director Smith Michael R
- SEC Form 4 filed by Director Cashaw Brad
- Director Vergis Janet S. was granted 736 shares, increasing direct ownership by 4% to 21,188 units (SEC Form 4)
- Director Price Penry W was granted 1,471 shares, increasing direct ownership by 5% to 33,321 units (SEC Form 4)
- SEC Form 4 filed by EVP of Strategy, M&A, and BP Buchert Brian D
- SEC Form 4 filed by President and CEO Dierker Richard A
Latest WALD
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
- SEC Form 6-K filed by Waldencast plc
- Waldencast Announces Sale of Obagi Medical to Bridgepoint
- Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
- Obagi and Next Health Partner to Launch "The Skin Recharge Station" Pop-Up Experience
- Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
- Waldencast announces conclusion of SEC investigation
- SEC Form 6-K filed by Waldencast plc